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Abstract 
Segmental ureterectomy is less invasive than radical nephroureterectomy and results in nephron preservation and 
satisfactory tumor control. This study was to determine the feasibility of segmental ureteroileal conduit resection 
(SUICR) for patients with distal upper urinary tract recurrence of bladder cancer following radical cystectomy. Four 
patients with high‑grade distal upper urinary tract recurrence underwent SUICR 15–108 months after radical cystec‑
tomy. The surgical technique details of SUICR, operative results, and follow‑up outcomes are reported. The median 
operation time was 280 min, and estimated blood loss was less than 100 mL. One patient suffered from ileus 5 days 
after surgery and was managed conservatively. Histopathologic evaluation showed high‑grade stages pTa‑pT1 
diseases for these patients, and ureteral margins were all negative. No patient suffered from tumor recurrence, with 
a median follow‑up of 39 months. SUICR preserved the ipsilateral renal unit and conformed to oncological principles 
during surgery. The oncological outcome was satisfactory for these properly selected patients. This technique pro‑
vides a valid alternative to nephroureterectomy for patients with imperative indications and high‑grade upper urinary 
tract recurrence of bladder cancer following radical cystectomy.
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Background
Upper urinary tract recurrence of bladder cancer follow-
ing radical cystectomy is extremely rare, with a reported 
incidence ranging from 0.75% to 6.4% after cystectomy 
[1, 2]. The characteristics of the clinical course of upper 
urinary tract recurrence are thus not yet fully under-
stood. As urothelial carcinoma is a multifocal disease 
affecting the entire urothelium, radical nephroureterec-
tomy (RNU) with bladder cuff excision is the standard 
treatment for urothelial carcinoma of the upper urinary 
tract regardless of the location of the tumor because 
it eliminates the risk of ipsilateral recurrence [1]. How-
ever, RNU increases the risk of renal function decline 
and cardiovascular events and affects the eligibility for 
adjuvant chemotherapy. Furthermore, patients undergo-
ing RNU are still at life-long risk of upper urinary tract 
recurrence in the remaining renal unit [2, 3]. As a result, 
renal-sparing surgeries for patients with urothelial carci-
noma of the upper urinary tract, e.g., segmental ureterec-
tomy, laser endoscopic ablation, and percutaneous tumor 
ablation, have been developed for patients under certain 
conditions [4–7]. The long-term survival rates of patients 
after RNU and renal-sparing surgery were comparable 
in several retrospective studies with long-term follow-
up [3, 5, 8, 9]. In addition, renal-sparing management is 
more cost-effective than RNU [10]. Even for patients with 
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a normal contralateral kidney, by sparing the ipsilateral 
kidney, more patients will be eligible for and benefit from 
adjuvant or salvage chemotherapy if it is required [6, 11].
Segmental ureterectomy is recommended by The 
National Comprehensive Cancer Network guidelines for 
properly selected patients, e.g., renal insufficiency, soli-
tary functional kidney, and low-grade middle or distal 
ureteral tumors [12]. Unlike other conservative treat-
ments of upper urinary tract recurrence, such as endo-
scopic ablation, segmental ureterectomy is the only 
renal-sparing procedure that enables intraoperative 
analysis of excision margins and accurate histopathologic 
examination, both of which are crucial for predicting 
prognosis [6, 8]. Furthermore, the largest retrospective 
series involving 2044 patients showed that the 5-year 
cancer-specific survival rate was comparable between 
segmental ureterectomy and RNU groups, suggesting 
that segmental ureterectomy did not undermine cancer 
control outcomes [7]. This result was also confirmed by 
several other multicenter retrospective studies [3, 8, 11].
To the best of our knowledge, there are few stud-
ies applying segmental ureterectomy for patients with 
upper urinary tract recurrence of bladder cancer follow-
ing radical cystectomy, as this is an extremely rare dis-
ease requiring proficient surgical technique. The present 
study aimed to introduce the technique of segmental ure-
teroileal conduit resection (SUICR) for the treatment of 
distal upper urinary tract recurrence of bladder cancer 
following radical cystectomy.
Case report
Between June 2009 and March 2014, four patients 
were diagnosed with high-grade upper urinary tract 
recurrence in the distal ureter (defined as the distal 1/3 
of the ureter) following radical cystectomy for blad-
der cancer and underwent SUICR.  Individual charac-
teristics of the patients and features of upper urinary 
tract recurrence are summarized in Table  1. No patient 
received chemotherapy or radiotherapy previously. The 
preoperative evaluation included intravenous urography, 
computed tomography, magnetic resonance urography, 
flexible cystoscope, urinary cytology, and serum creati-
nine detection. Ureteroscopy was performed for tumor 
biopsy, and several steps were taken to avoid tumor 
implantation in the upper ureter, i.e., a low water injec-
tion pressure, low-dose diuretics used during operation, 
and protecting the healthy urothelium from injury. Indi-
cations for SUICR included solitary kidney or impaired 
renal function caused by hydroureteronephrosis. Opera-
tions were performed after detailed information about 
SUICR was provided to patients and informed consent 
was obtained. Because all interventions given were part 
of normal health care, ethical approval was not required.
Under general anesthesia, the patients were placed in 
a supine position. An approximate 15-cm low-abdominal 
incision was made in the previous cystectomy incision 
site. Due to previous open surgery, extensive enteroly-
sis with sharp dissection was performed first, and care 
needed to be taken not to compromise the intestine. Sur-
geons would then have good access to the ileal conduit 
and ureter (Fig.  1a). The lysis of the ileal conduit from 
local adhesions was then performed, and the ureter was 
carefully dissected from beyond the bifurcation of the 
iliac vessels to the urinary diversion. The affected ure-
ter was ligated 2  cm proximal to the ureter tumor, and 
direct contact with the tumor was avoided through these 
Table 1 Clinical features of  four patients with  distal upper urinary tract recurrence of  bladder cancer following  cystec-
tomy
SUICR segmental ureteroileal conduit resection; CIS carcinoma in situ
a Tumor staging and grading were based on the 2009 International Union Against Cancer TNM classification and the 2004 World Health Organization system. 
G3 = high-grade
b Distal ureter was defined as the distal 1/3 of the ureter






















1 73 Male G3 with CIS, 
T1N0M0
34 Right, distal Microscopic  
hematuria
Solitary kidney 132 129
2 68 Male G3, T2N0M0 28 Right, distal Hematuria Solitary kidney 110 116
3 64 Male G3, T1N0M0 15 Left, distal Hematuria and posi‑
tive urinary cytology
Solitary kidney 96 101
4 66 Male G3, T2N0M0 108 Right, distal Hematuria and posi‑
tive urinary cytology
Declined renal func‑
tion caused by 
hydronephrosis
354 136
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procedures. For one patient with hydroureteronephrosis, 
distal upper urinary tract recurrence was suspected on 
both sides, and the contralateral ureter was also ligated 
(Fig. 1b). The ileal conduit was clipped with an intestinal 
clamp approximately 3–4  cm distal to the ureteroileal 
conduit anastomosis, and segmental resection of the 
compromised ureteroileal conduit was then performed 
(Fig.  1b). Frozen sections of the proximal ureteral mar-
gin were generated, and the proximal ureter was resected 
until the frozen sections were negative. The transected 
ureter was finally reanastomosed to the ileal conduit by 
routine procedures in radical cystectomy with ileal con-
duit diversion as described previously [13]. A single-J 
ureteral stent was placed before closing the anastomosis 
(Fig. 1c). Lymphadenectomy was not performed for these 
patients. Finally, drainage catheters were placed in the 
lower abdomen and stoma (Fig. 1d). A schematic draw-
ing of SUICR is shown in Fig. 2. Pathologic evaluation of 
tumor stage and grade were based on the 2009 Interna-
tional Union Against Cancer TNM classification and the 
2004 World Health Organization system [14, 15].
SUICR was performed successfully in all four patients 
without major intraoperative complications. Detailed 
information on the intra- or postoperative characteristics 
of the surgery is shown in Table 2. The median operation 
time was 280 min, and the estimated blood loss was less 
than 100 mL. The changes in serum creatinine before and 
after surgery are shown in Table  1. The median time to 
liquid intake was 3 days, and median hospital stay after 
surgery was 5.5  days. One patient suffered from ileus 
5  days after surgery and was managed conservatively. 
Frozen sections and histopathologic evaluation of the 
resected ureter margins were all negative. The histo-
pathologic analysis revealed non-muscle invasive, high-
grade urothelial carcinoma in these patients (pTa-pT1). 
The single-J stent was removed 8  weeks after surgery. 
No patient received chemotherapy or radiotherapy after 
SUICR.
Postoperative surveillance consisted of urinalysis, 
serum creatinine detection, and urinary system ultra-
sonography every 3  months in the first year and every 
6  months thereafter. Urinary cytology, abdominal com-
puted tomography, intravenous urography, or magnetic 
resonance urography was performed every 6  months in 
the first 3 years and annually thereafter. Flexible cystos-
copy and ureteroscopy were only indicated in cases of 
suspicious urinary cytology and radiological imaging.
Patients were followed for a median of 39  months 
(range, 13–66  months), and all of them were still alive. 
No upper urothelial carcinoma recurrence or declined 
Fig. 1 Segmental ureteroileal conduit resection procedures. a. The ileal conduit (black arrow) and the affected ureter (white arrow) were exposed. 
b. The ureters and ileal conduit were segmentally removed. c. The transected ureter was reanastomosesed to the residual ileal conduit. d. Drainage 
catheters were placed in the lower abdomen and stoma
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renal function was diagnosed. One patient suffered from 
ureteroileal conduit anastomotic stricture 11  months 
after SUICR, and was successfully treated with ureteral 
stent dilations and retrograde placement of single-J stent 
guided by flexible cystoscope [16].
Discussion
In the present study, we conformed to the oncological 
principles of segmental ureterectomy and modified this 
technique to treat properly selected patients with upper 
urinary tract recurrence of bladder cancer following 
radical cystectomy. The major advantage of this modified 
technique was to preserve the function of the kidney. The 
conduit was not completely removed to perform uret-
erocutaneostomy because the ureter was not long enough 
to reach tension-free anastomosis after the distal portion 
was removed. Four patients underwent SUICR. Three of 
them had a solitary kidney, and one had renal function 
insufficiency due to hydroureteronephrosis caused by 
suspicious distal ureter tumor recurrence on both sides. 
None of these patients developed tumor recurrence, with 
a median follow-up of 39 months. These results suggest 
that SUICR is promising for properly selected patients 
with upper urinary tract recurrence, and it can achieve 
valid tumor control.
The reported incidence of urothelial tumors of the distal 
ureter (70%) is higher than that of the middle (25%) or prox-
imal ureter (5%) [17, 18]. Urothelial tumors of the distal ure-
ter were more likely to be solitary, small, and low-risk than 
those in the upper parts. They recur less frequently, and 
endoscopic treatment might thus be proposed for low-grade 
tumors [18]. For high-grade upper urinary tract recurrence, 
a more aggressive treatment modality is needed. As a result, 
SUICR might be a valuable alternative to RNU for patients 
with high-grade distal upper urinary tract recurrence and 
imperative indications. Selecting patients who would ben-
efit more from this technique remains a challenge, and 
the technique is generally only recommended for patients 
with imperative indications. However, Jeldres et al. [7] sug-
gested that segmental ureterectomy might be suitable for 
all patients with urothelial tumors when it was technically 
feasible, even including carefully selected patients with stage 
T3 or T4 disease. In contrast, Li et  al. [19] recommended 
segmental ureterectomy only for patients with unilateral 
low-grade and noninvasive tumors, as patients who under-
went distal ureterectomy had shorter recurrence-free sur-
vival compared with patients who underwent RNU.
SUICR is a complex technique because of the exten-
sive adhesion and altered anatomy in the abdomen. 
To assure a satisfactory outcome, attention needs to be 
paid to several important points. First, to minimize the 
risk of tumor spillage, direct contact with the tumor 
Fig. 2 Schematic drawing of the segmental ureteroileal conduit 
resection technique. a and b, The tumor to be segmentally removed 
(indicates by the dashed line). c and d, Patients after segmental ureter‑
oileal conduit resection operation
Table 2 Results of patients who underwent SUICR
Abbreviation as in Table 1. All patients are recurrence-free at present
Patient Operation  
duration (min)














1 300 <100 None 6 G3, T1N0M0 66 None
2 240 <100 None 5 G3, TaN0M0 46 Ureteroileal conduit 
anastomosis 
stricture
3 320 <100 Ileus 8 G3, T1N0M0 32 None
4 260 <100 None 5 G3, TaN0M0 13 None
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should be avoided, and blockage proximal and distal 
to the tumor, with at least 2-cm safe margin, should be 
performed when the ureter and ileal conduit are ade-
quately freed. Second, iliac vessels and intestines should 
be carefully protected when performing enterolysis and 
releasing the ureter and ileal conduit from adjacent tis-
sues. Third, to achieve tension-free ureteroileal conduit 
anastomosis, the ureter should be freed as long as pos-
sible, and a new ileal conduit should be constructed if 
required. Last but not least, as urothelial carcinoma is a 
multifocal disease, patients should be willing to follow 
stringent surveillance. Although patients who under-
went segmental ureterectomy were advised to adhere to 
more-aggressive life-long surveillance, the optimum regi-
men for upper urinary tract recurrence following radical 
cystectomy remains controversial [20, 21]. The majority 
of upper urinary tract recurrence was detected based on 
symptoms rather than radiological or cytological surveil-
lance. Approximately 800 radiological examinations were 
performed to identify only one patient with upper uri-
nary tract recurrence [21–23]. Limitations of the SUICR 
technique should be addressed. Although the oncological 
outcome in our modified technique was satisfactory, only 
four patients underwent our modified technique, with no 
control group. This was due to the paucity of upper uri-
nary tract recurrence following radical cystectomy, and 
RNU was still regarded as the standard treatment. Mean-
while, whether SUICR could be successfully performed 
also depends on the previous operation style and intraop-
erative exploration. However, this study primarily intro-
duced an alternative technique for urologists to address 
some challenging tasks of upper urinary tract recurrence 
following radical cystectomy, and patients were also likely 
to benefit from this treatment.
Conclusions
SUICR preserves the ipsilateral renal unit and conforms 
to oncological principles during surgery. Although 
this technique is technically demanding, it is less com-
plex and invasive than RNU. Moreover, the oncological 
outcome of this technique is satisfactory for properly 
selected patients. In aggregate, SUICR provides a valid 
alternative to RNU for patients with imperative indica-
tions and high-grade upper urinary tract recurrence of 
bladder cancer following radical cystectomy.
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